Apeloa Pharmaceutical Co.,Ltd
000739
Pozycja w akcjach
#4311
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Cena akcji
$3.17
Kapitalizacja rynkowa
$3.67B
Zmiana (1 dzień)
0.76%
Zmiana (1 rok)
40.57%
Kraj
CN
Handel Apeloa Pharmaceutical Co.,Ltd (000739)
Kategoria
Healthcare
Historia stopy dywidendy dla Apeloa Pharmaceutical Co.,Ltd (000739)
Stopa dywidendy (TTM) dla Apeloa Pharmaceutical Co.,Ltd (symbol akcji: 000739) na dzień 2023-12-31 wynosi: 2.11%
Średnia stopa dywidendy z ostatnich 5 lat: 1.39%
Średnia stopa dywidendy z ostatnich 5 lat: 1.39%
Historia stopy dywidendy dla Apeloa Pharmaceutical Co.,Ltd (000739) od 2000 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| 2026 (TTM) | 1.58% | -25.82% |
| 2024 | 2.13% | 0.95% |
| 2023 | 2.11% | 58.65% |
| 2022 | 1.33% | 92.75% |
| 2021 | 0.69% | -2.82% |
| 2020 | 0.71% | -16.47% |
| 2019 | 0.85% | -37.96% |
| 2018 | 1.37% | -27.51% |
| 2017 | 1.89% | 26.00% |
| 2016 | 1.50% | -13.29% |
| 2015 | 1.73% | 61.68% |
| 2014 | 1.07% | -43.68% |
| 2013 | 1.90% | -63.60% |
| 2012 | 5.22% | 338.66% |
| 2011 | 1.19% | -10.53% |
| 2010 | 1.33% | -8.90% |
| 2009 | 1.46% | -60.96% |
| 2008 | 3.74% | 128.05% |
| 2007 | 1.64% | -45.15% |
| 2006 | 2.99% | -43.58% |
| 2005 | 5.30% | 46.81% |
| 2004 | 3.61% | 37.79% |
| 2003 | 2.62% | 12.93% |
| 2002 | 2.32% | 286.67% |
| 2001 | 0.60% | 81.82% |
| 2000 | 0.33% | 0.00% |
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
